Search
RBC Global Healthcare Conference: Korro Bio entered the clinic with its RNA editing platform in January and will have multiple cohorts of data in AATD later this year
CEO Ram Aiyar describes Korro's 'OPERA' platform and explains why he thinks it is differentiated from others in the field. He previews...
2 days ago
Korro Bio's Ram Aiyar and Novo Nordisk's Uli Stilz discuss their RNA editing collaboration, the field of genetic medicine, and the future of drug discovery
Ram Aiyar, President & CEO of Korro Bio, and Uli Stilz, Head of Novo Nordisk's Bio Innovation Hub in Kendall Square, share their...
Mar 5
Korro Bio CEO on RNA editing and the process behind reverse mergers
Ram Aiyar discusses RNA editing and the news announced Friday that his company Korro Bio is aiming to do a reverse merge to go public.
Jul 17, 2023
.png){kind=logo}
